» Articles » PMID: 20150237

Variation and Molecular Evolution of HmbR, the Neisseria Meningitidis Haemoglobin Receptor

Overview
Specialty Microbiology
Date 2010 Feb 13
PMID 20150237
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Meningococcal disease caused by serogroup B Neisseria meningitidis remains an important health problem in many parts of the world, and there are currently no comprehensive vaccines. Poor immunogenicity, combined with immunological identity to human sialic acids, have hindered the development of a serogroup B conjugate vaccine, resulting in the development of alternative vaccine candidates, including many outer-membrane protein (OMP)-based formulations. However, the design of protein-based meningococcal vaccines is complicated by the high level of genetic and antigenic diversity of the meningococcus. Knowledge of the extent and structuring of this diversity can have implications for the use of particular proteins as potential vaccine candidates. With this in mind, the diversity of the meningococcal OMP HmbR was investigated among N. meningitidis isolates representative of major hyper-invasive lineages. In common with other meningococcal antigens, the genetic diversity of hmbR resulted from a combination of intraspecies horizontal genetic exchange and de novo mutation. Furthermore, genealogical analysis showed an association of hmbR genes with clonal complexes and the occurrence of two hmbR families, A and B. Three variable regions (VR1-VR3), located in loops 2, 3 and 4, were observed with clonal complex structuring of VR types. A minority of codons (3.9 %), located within putative surface-exposed loop regions of a 2D model, were under diversifying selection, indicating regions of the protein likely to be subject to immune attack.

Citing Articles

The Diversity of Mammalian Hemoproteins and Microbial Heme Scavengers Is Shaped by an Arms Race for Iron Piracy.

Mozzi A, Forni D, Clerici M, Cagliani R, Sironi M Front Immunol. 2018; 9:2086.

PMID: 30271410 PMC: 6142043. DOI: 10.3389/fimmu.2018.02086.


Metagenomics Reveals Dysbiosis and a Potentially Pathogenic N. flavescens Strain in Duodenum of Adult Celiac Patients.

DArgenio V, Casaburi G, Precone V, Pagliuca C, Colicchio R, Sarnataro D Am J Gastroenterol. 2016; 111(6):879-90.

PMID: 27045926 PMC: 4897008. DOI: 10.1038/ajg.2016.95.


Investigation into the Antigenic Properties and Contributions to Growth in Blood of the Meningococcal Haemoglobin Receptors, HpuAB and HmbR.

Bidmos F, Chan H, Praekelt U, Tauseef I, Ali Y, Kaczmarski E PLoS One. 2015; 10(7):e0133855.

PMID: 26208277 PMC: 4514712. DOI: 10.1371/journal.pone.0133855.


Structural conservation, variability, and immunogenicity of the T6 backbone pilin of serotype M6 Streptococcus pyogenes.

Young P, Moreland N, Loh J, Bell A, Atatoa Carr P, Proft T Infect Immun. 2014; 82(7):2949-57.

PMID: 24778112 PMC: 4097639. DOI: 10.1128/IAI.01706-14.


The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysis.

Lucidarme J, Findlow J, Chan H, Feavers I, Gray S, Kaczmarski E PLoS One. 2013; 8(9):e76932.

PMID: 24098814 PMC: 3786947. DOI: 10.1371/journal.pone.0076932.


References
1.
Ferguson A, Hofmann E, Coulton J, Diederichs K, Welte W . Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science. 1998; 282(5397):2215-20. DOI: 10.1126/science.282.5397.2215. View

2.
Lewis L, Gipson M, Hartman K, Ownbey T, Vaughn J, Dyer D . Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of Neisseria meningitidis DNM2. Mol Microbiol. 1999; 32(5):977-89. DOI: 10.1046/j.1365-2958.1999.01409.x. View

3.
Jolley K, Feil E, Chan M, Maiden M . Sequence type analysis and recombinational tests (START). Bioinformatics. 2001; 17(12):1230-1. DOI: 10.1093/bioinformatics/17.12.1230. View

4.
Schmidt H, Strimmer K, Vingron M, von Haeseler A . TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics. 2002; 18(3):502-4. DOI: 10.1093/bioinformatics/18.3.502. View

5.
Madico G, Welsch J, Lewis L, McNaughton A, Perlman D, Costello C . The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol. 2006; 177(1):501-10. PMC: 2248442. DOI: 10.4049/jimmunol.177.1.501. View